A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis

被引:181
|
作者
Krentel, Alison [1 ,2 ]
Fischer, Peter U. [1 ]
Weil, Gary J. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA
[2] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England
来源
PLOS NEGLECTED TROPICAL DISEASES | 2013年 / 7卷 / 11期
基金
比尔及梅琳达.盖茨基金会;
关键词
NEGLECTED TROPICAL DISEASES; RURAL-AREAS; WESTERN PROVINCE; ORISSA STATE; TAMIL-NADU; PROGRAM; INDIA; COMMUNITY; IMPACT; COVERAGE;
D O I
10.1371/journal.pntd.0002447
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The success of programs to eliminate lymphatic filariasis (LF) depends in large part on their ability to achieve and sustain high levels of compliance with mass drug administration (MDA). This paper reports results from a comprehensive review of factors that affect compliance with MDA. Methodology/Principal Findings: Papers published between 2000 and 2012 were considered, and 79 publications were included in the final dataset for analysis after two rounds of selection. While results varied in different settings, some common features were associated with successful programs and with compliance by individuals. Training and motivation of drug distributors is critically important, because these people directly interact with target populations, and their actions can affect MDA compliance decisions by families and individuals. Other important programmatic issues include thorough preparation of personnel, supplies, and logistics for implementation and preparation of the population for MDA. Demographic factors (age, sex, income level, and area of residence) are often associated with compliance by individuals, but compliance decisions are also affected by perceptions of the potential benefits of participation versus the risk of adverse events. Trust and information can sometimes offset fear of the unknown. While no single formula can ensure success MDA in all settings, five key ingredients were identified: engender trust, tailor programs to local conditions, take actions to minimize the impact of adverse events, promote the broader benefits of the MDA program, and directly address the issue of systematic non-compliance, which harms communities by prolonging their exposure to LF. Conclusions/Significance: This review has identified factors that promote coverage and compliance with MDA for LF elimination across countries. This information may be helpful for explaining results that do not meet expectations and for developing remedies for ailing MDA programs. Our review has also identified gaps in understanding and suggested priority areas for further research.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India
    Bashar, Abu
    Nandekar, Sanket, V
    Shrivastava, Prerna
    Singh, Ravi Nandini
    Srikrishnan, Pushkar
    JOURNAL OF VECTOR BORNE DISEASES, 2023, 60 (03) : 307 - 316
  • [32] SOCIO-ECONOMIC AND BEHAVIORAL FACTORS THAT INFLUENCE COMPLIANCE WITH MASS TREATMENT IN THE NATIONAL PROGRAMME FOR ELIMINATION OF LYMPHATIC FILARIASIS IN KENYA
    Njomo, Doris W.
    Nyamongo, Mary A.
    Njenfa, Sammy M.
    Magambo, Japheth K.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (05): : 67 - 67
  • [33] Albenclazole for mass drug administration to eliminate lymphatic filariasis
    Sabesan, Shanmugavelu
    LANCET INFECTIOUS DISEASES, 2006, 6 (11): : 684 - 685
  • [34] A strong effect of individual compliance with mass drug administration for lymphatic filariasis on sustained clearance of soil-transmitted helminth infections
    Campillo, Jeremy T.
    Awaca-Uvon, Naomi P.
    Tambwe, Jean-Paul
    Kuyangisa-Simuna, Godefroy
    Vlaminck, Johnny
    Weil, Gary J.
    Boussinesq, Michel
    Chesnais, Cedric B.
    Pion, Sebastien D. S.
    PARASITES & VECTORS, 2021, 14 (01)
  • [35] A strong effect of individual compliance with mass drug administration for lymphatic filariasis on sustained clearance of soil-transmitted helminth infections
    Jérémy T. Campillo
    Naomi P. Awaca-Uvon
    Jean-Paul Tambwe
    Godefroy Kuyangisa-Simuna
    Johnny Vlaminck
    Gary J. Weil
    Michel Boussinesq
    Cédric B. Chesnais
    Sébastien D. S. Pion
    Parasites & Vectors, 14
  • [36] Mass drug administration to eliminate lymphatic filariasis in India
    Ramaiah, KD
    Das, PK
    TRENDS IN PARASITOLOGY, 2004, 20 (11) : 499 - 502
  • [37] Factors influencing implementation of mass drug administration for lymphatic filariasis elimination: a mixed-method study in Odisha, India
    Ratna, P.
    Sinha, Abhinav
    Pati, Sanghamitra
    Sahoo, Prakash Kumar
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [38] Impediments to compliance during filariasis mass drug administration-Observations and recommendations to accelerate filariasis elimination in India
    Abraham, Philip Raj
    Kuttiatt, Vijesh Sreedhar
    Rahi, Manju
    Kumar, Ashwani
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [39] Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008
    Cantey, P. T.
    Rao, G.
    Rout, J.
    Fox, L. M.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (02) : 224 - 231
  • [40] Elimination of lymphatic filariasis in west African urban areas: is implementation of mass drug administration necessary?
    Koudou, Benjamin G.
    de Souza, Dziedzom K.
    Biritwum, Nana-Kwadwo
    Bougma, Roland
    Aboulaye, Meite
    Elhassan, Elizabeth
    Bush, Simon
    Molyneux, David H.
    LANCET INFECTIOUS DISEASES, 2018, 18 (06): : E214 - E220